文献速递瓣膜外科冠心病外科

美国心房颤动外科消融的趋势与倾向匹配结局

Surgical Ablation of Atrial Fibrillation in the United States: Trends and Propensity Matched Outcomes.
PubMed 文献 · Ann Thorac Surg · 2017-06-29

基于STS数据库2011年7月至2014年6月86,941例无内膜炎的房颤患者接受非急诊心脏手术,分析外科消融(SA)趋势并用倾向匹配28,739对比较结局。SA总体使用率48.3%且各术式均增加;匹配后SA与30天死亡和卒中相对风险降低相关,但肾衰竭和起搏器植入风险增加。

要点

  • 二尖瓣手术SA使用率最高(MVRR±CABG 68.4%),孤立CABG最低(32.8%)。
  • 匹配后SA与30天死亡(RR 0.92)和卒中(RR 0.84)风险降低相关。
  • SA与肾衰竭(RR 1.12)和起搏器植入(RR 1.33)风险增加相关。

核心结论

  • 当代SA在各手术类别中使用率均增加,并与30天死亡和卒中风险降低相关,但肾衰竭和起搏器植入风险增加。

研究设计与样本

  • 回顾性分析STS数据库2011年7月至2014年6月86,941例房颤患者接受非急诊心脏手术,按AF类型、主要术式和STS合并症变量进行1:1倾向匹配28,739对。

主要发现

  • 所有房颤患者中48.3%(42,066/86,941)接受SA;MVRR±CABG为68.4%(14,693/21,496),MVRR+AVR为59.1%(1,626/2,750)。
  • AVR±CABG为39.3%(6,816/17,349),孤立CABG为32.8%(9,156/27,924),其他伴随手术为47.6%(6,939/14,586)。
  • 倾向匹配后SA与30天死亡RR 0.92(95%CI 0.85-0.99)和卒中RR 0.84(95%CI 0.74-0.94)相关。
  • SA与肾衰竭RR 1.12(95%CI 1.03-1.22)和起搏器植入RR 1.33(95%CI 1.24-1.43)相关。

临床怎么用

  • 在房颤患者接受心脏手术时,可考虑同期SA以降低30天死亡和卒中风险。
  • 需权衡SA带来的肾衰竭和起搏器植入风险增加。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical ablation (SA) for atrial fibrillation (AF) effectively restores sinus rhythm. Incompletely defined risk has previously limited concomitant performance of SA during cardiac operations. The study goals were to define performance trends and risk-adjusted outcomes for contemporary SA. METHODS: From July 2011 to June 2014, 86,941 patients with AF, but without endocarditis, underwent primary nonemergent cardiac operations in The Society of Thoracic Surgeons (STS) database. Cochran-Armitage tests examined performance trends of SA for six operative categories: mitral valve repair or replacement (MVRR) with or without coronary artery bypass graft surgery (CABG), aortic valve replacement (AVR) with or without CABG, CABG, AVR with MVRR, stand-alone SA, and other concomitant operations. The risk of concomitant SA was analyzed by propensity matching 28,739 patient-pairs with and without SA by AF type, primary operation, and STS comorbid risk variables using greedy 1:1 matching algorithms. RESULTS: Among all patients with AF, 48.3% (42,066 of 86,941) underwent SA. Mitral operations had the highest rate of SA (MVRR ± CABG 68.4% [14,693 of 21,496]; MVRR + AVR 59.1% [1,626 of 2,750]). The AVR ± CABG and isolated CABG rates were 39.3% (6,816 of 17,349) and 32.8% (9,156 of 27,924), respectively. Nearly half of other concomitant operations underwent SA, 47.6% (6,939 of 14,586). Performance frequency increased throughout the study period. After propensity matching, SA was associated with a reduction in relative risk (RR) of 30-day mortality (RR 0.92, 95% confidence interval [CI]: 0.85 to 0.99) and stroke (RR 0.84, 95% CI: 0.74 to 0.94), but an increase in renal failure (RR 1.12, 95% CI: 1.03 to 1.22) and pacemaker implantation (RR 1.33, 95% CI: 1.24 to 1.43). CONCLUSIONS: Contemporary utilization of SA is increasing across all operative categories. Performance of SA is accompanied by a 30-day reduction in mortality and stroke. These findings further refine our understanding of the role of SA in the treatment of AF.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Badhwar V, Rankin JS, Ad N, et al. Surgical Ablation of Atrial Fibrillation in the United States: Trends and Propensity Matched Outcomes. Ann Thorac Surg. 2017. PMID: 28669501. doi:10.1016/j.athoracsur.2017.05.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。